JUNS
NASDAQ · Pharmaceuticals
Jupiter Neurosciences Inc
$0.24
+0.01 (+2.61%)
Open$0.23
Previous Close$0.23
Day High$0.26
Day Low$0.22
52W High$3.33
52W Low$0.17
Volume—
Avg Volume1.82M
Market Cap11.48M
P/E Ratio—
EPS$-0.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+18,514.4% upside
Current
$0.24
$0.24
Target
$43.93
$43.93
$31.75
$43.93 avg
$69.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 28.9K | 89.2K | 3.89M |
| Net Income | -12,036,737 | -33,383,862 | 896.5K |
| Profit Margin | -39,655.5% | -37,672.7% | 23.1% |
| EBITDA | -12,408,063 | -36,325,608 | 1.23M |
| Free Cash Flow | — | — | 754.2K |
| Rev Growth | -67.6% | -67.6% | +2.3% |
| Debt/Equity | 0.04 | 0.04 | 0.24 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |